+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Critical Care Adsorption Solutions Market - Global Forecast 2026-2032- Product Image
Critical Care Adsorption Solutions Market - Global Forecast 2026-2032- Product Image
Sale

Critical Care Adsorption Solutions Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6078995
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Critical Care Adsorption Solutions Market is projected to reach USD 853.18 Million in 2026. It is expected to continue growing at a CAGR of 9.92%, reaching USD 1.49 Billion by 2032.

Critical Care Adsorption Solutions: Executive Overview

Critical care adsorption solutions use extracorporeal technologies to remove selected toxins, inflammatory mediators, drugs, or other pathogenic substances from blood or plasma. Their clinical relevance is tied to severe conditions such as sepsis, poisoning, liver dysfunction, and systemic inflammatory states. Adoption depends on evidence quality, treatment protocols, device compatibility, reimbursement, clinician expertise, and the ability to integrate therapies into intensive-care workflows.

Clinical Integration Is Reshaping Adsorption Therapy

The landscape is shifting from use in narrowly defined rescue scenarios toward more protocolized, indication-specific applications. Hospitals are placing greater emphasis on patient selection, treatment timing, anticoagulation management, monitoring requirements, and measurable clinical endpoints. Regulatory scrutiny and demand for comparative evidence are also encouraging manufacturers and care providers to distinguish biological plausibility from demonstrated patient benefit.

Artificial Intelligence Is Strengthening Patient Selection and Monitoring

Artificial intelligence can support critical-care adsorption by combining laboratory results, hemodynamic data, medication exposure, organ-function indicators, and longitudinal clinical records. Potential applications include identifying patients who may benefit from extracorporeal removal, detecting treatment-related changes, optimizing treatment duration, and flagging complications. These tools should remain decision-support systems, with validation across diverse intensive-care populations, transparent performance measures, cybersecurity safeguards, and clinician oversight.

Regional Insights: Regulation, Evidence, and Critical-Care Capacity Differ

North America emphasizes clinical evidence, regulatory compliance, and integration with advanced intensive-care systems. Europe combines structured health-technology assessment with established critical-care networks, while the European Union faces variation in national reimbursement and implementation pathways. Asia-Pacific includes technologically advanced systems alongside rapidly expanding critical-care capacity, creating varied access and evidence environments. Latin America is influenced by procurement constraints, uneven availability of specialized staff, and public-private differences. The Middle East is developing tertiary-care capabilities but experiences uneven access across countries. Africa generally faces stronger limitations in equipment availability, trained personnel, supply continuity, and research infrastructure, making scalable protocols and regional training especially important.

Group Insights: Economic and Security Alliances Shape Access

ASEAN countries show differing levels of intensive-care capacity, regulatory maturity, and dependence on imported medical technologies. BRICS members span large and diverse health systems, with opportunities for domestic production, local clinical research, and broader access but substantial variation in infrastructure. The European Union benefits from collaborative scientific and regulatory structures while retaining national differences in purchasing and reimbursement. G7 systems generally have mature critical-care capabilities and stronger evidence-generation resources. GCC countries are investing in advanced hospital infrastructure and specialist care, although workforce localization and supply resilience remain relevant. NATO members may benefit from shared preparedness priorities, but civilian adoption still depends on national clinical and health-system decisions.

Country Insights: National Systems Determine Adoption Pathways

Australia and Canada must address geographic dispersion and specialist access alongside strong clinical governance. Brazil, Mexico, India, and Russia face substantial internal variation in hospital resources, procurement, and specialist availability. China and South Korea combine advanced tertiary-care capabilities with active technology development, while Japan emphasizes rigorous clinical practice and an aging-care context. France, Germany, Italy, Spain, and the United Kingdom operate within sophisticated health systems but differ in assessment, reimbursement, and hospital purchasing processes. The United States has extensive critical-care capability and research activity, with adoption shaped by evidence, regulation, hospital protocols, and payer considerations.

Priorities for Leaders: Build Evidence, Workflow Fit, and Resilience

Industry leaders should define precise clinical indications and generate prospective, clinically meaningful evidence rather than relying solely on surrogate biomarkers. Products should be designed for straightforward integration with existing extracorporeal circuits, clear anticoagulation guidance, robust safety monitoring, and minimal disruption to intensive-care workflows. Organizations should establish multidisciplinary protocols involving intensivists, nephrologists, pharmacists, nurses, laboratory teams, and procurement leaders. Regional strategies should account for reimbursement, training capacity, maintenance, consumables, and supply continuity. Responsible use of artificial intelligence requires validated datasets, explainable outputs, privacy controls, and explicit clinician accountability.

Research Methodology: Evidence-Led Market Interpretation

This executive summary interprets the critical care adsorption solutions landscape through a structured review of clinical use cases, treatment workflows, technology requirements, regulatory considerations, health-system capacity, and geographic implementation conditions. Regional, group, and country observations are framed qualitatively to avoid unsupported market estimates. The assessment prioritizes verifiable themes from clinical practice, public health-system characteristics, scientific evidence standards, and technology adoption requirements, while recognizing that local protocols and reimbursement policies can change over time.

Conclusion: Adoption Depends on Demonstrated Clinical Value

Critical care adsorption solutions occupy an important but evidence-sensitive position within extracorporeal medicine. Their long-term role will depend on identifying patients most likely to benefit, demonstrating outcomes that matter to patients and health systems, and ensuring safe integration into complex intensive-care environments. Progress will be strongest where clinical research, workforce training, responsible data use, regulatory alignment, and resilient supply planning advance together.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Critical Care Adsorption Solutions Market, by Product Type
7.1. Introduction
7.2. Hemofiltration Adsorber
7.2.1. Regenerative Filter
7.2.2. Synthetic Filter
7.3. Hemoperfusion Cartridge
7.3.1. Continuous Flow
7.3.2. Intermittent Flow
7.4. Plasma Adsorption Column
7.4.1. Cytosorb Cartridge
7.4.2. Polymyxin B Column
8. Critical Care Adsorption Solutions Market, by Technology
8.1. Introduction
8.2. Extracorporeal
8.2.1. Continuous
8.2.2. Intermittent
8.3. Intravascular
8.3.1. Central
8.3.2. Peripheral
9. Critical Care Adsorption Solutions Market, by Adsorbent Material
9.1. Introduction
9.2. Activated Carbon
9.2.1. Granular
9.2.2. Powdered
9.3. Synthetic Polymer
9.3.1. Polymethyl Methacrylate
9.3.2. Styrene Divinylbenzene
9.4. Zeolites
9.4.1. Clinoptilolite
9.4.2. Mordenite
10. Critical Care Adsorption Solutions Market, by Patient Type
10.1. Introduction
10.2. Adult
10.3. Neonatal
10.3.1. Full Term
10.3.2. Preterm
10.4. Pediatric
10.4.1. Infant
10.4.2. Toddler
11. Critical Care Adsorption Solutions Market, by Application
11.1. Introduction
11.2. Cytokine Storm
11.2.1. CAR-T Therapy
11.2.2. COVID-19
11.3. Drug Overdose
11.3.1. Acetaminophen
11.3.2. Opioid
11.4. Liver Failure
11.4.1. Acute
11.4.2. Chronic
11.5. Sepsis
11.5.1. Gram Negative
11.5.2. Gram Positive
12. Critical Care Adsorption Solutions Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Hospitals
12.3.1. Non-Teaching
12.3.2. Teaching
12.4. Research Institutes
13. Critical Care Adsorption Solutions Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Critical Care Adsorption Solutions Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Critical Care Adsorption Solutions Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Adsorba Medical AB
17.2. Aferetica S.r.l.
17.3. Asahi Kasei Medical Co., Ltd.
17.4. B. Braun Melsungen AG
17.5. Baxter International Inc.
17.6. BioLogic-DT, LLC
17.7. Bionic Medizintechnik GmbH
17.8. CytoSorbents Corporation
17.9. CytoSorbents Europe GmbH
17.10. ExThera Medical Corporation
17.11. Fresenius Medical Care AG & Co. KGaA
17.12. Gambro AB
17.13. Hemoclean Co., Ltd.
17.14. Jafron Biomedical Co., Ltd.
17.15. Jiangsu Jafron Biomedical Co., Ltd.
17.16. Kaneka Corporation
17.17. Kawasumi Laboratories, Inc.
17.18. Medica S.p.A.
17.19. Medtronic plc
17.20. Nikkiso Co., Ltd.
17.21. Nipro Corporation
17.22. Polymed Medical Devices
17.23. SeaStar Medical Holding Corporation
17.24. Shandong Qidong Medical Devices Co., Ltd.
17.25. Spectral Medical Inc.
17.26. Suzhou Tiancheng Medical Devices Co., Ltd.
17.27. Terumo Corporation
17.28. Toray Industries, Inc.
17.29. Toray Medical Co., Ltd.
17.30. Zhejiang Tianjin Medical Devices Co., Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Critical Care Adsorption Solutions Market, Years Considered for the Study
FIGURE 2. Global Critical Care Adsorption Solutions Market, Research Design
FIGURE 3. Global Critical Care Adsorption Solutions Market, Research Framework
FIGURE 4. Global Critical Care Adsorption Solutions Market, Data Triangulation
FIGURE 5. Global Critical Care Adsorption Solutions Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Critical Care Adsorption Solutions Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Critical Care Adsorption Solutions Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Critical Care Adsorption Solutions Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Critical Care Adsorption Solutions Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2025 vs 2032 (%)
FIGURE 11. Global Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Critical Care Adsorption Solutions Market Size, by Patient Type, 2025 vs 2032 (%)
FIGURE 13. Global Critical Care Adsorption Solutions Market Size, by Patient Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Critical Care Adsorption Solutions Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Critical Care Adsorption Solutions Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Critical Care Adsorption Solutions Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Critical Care Adsorption Solutions Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Critical Care Adsorption Solutions Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Critical Care Adsorption Solutions Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Critical Care Adsorption Solutions Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Critical Care Adsorption Solutions Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Critical Care Adsorption Solutions Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Critical Care Adsorption Solutions Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Critical Care Adsorption Solutions Market Segmentation & Coverage
TABLE 2. Global Critical Care Adsorption Solutions Market Size, 2017-2032 (USD Million)
TABLE 3. Global Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Hemofiltration Adsorber Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Hemofiltration Adsorber Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Hemofiltration Adsorber Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Regenerative Filter Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Regenerative Filter Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Regenerative Filter Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Synthetic Filter Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Synthetic Filter Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Synthetic Filter Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Hemoperfusion Cartridge Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Hemoperfusion Cartridge Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Hemoperfusion Cartridge Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Continuous Flow Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Continuous Flow Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Continuous Flow Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Intermittent Flow Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Intermittent Flow Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Intermittent Flow Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Plasma Adsorption Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Plasma Adsorption Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Plasma Adsorption Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Cytosorb Cartridge Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Cytosorb Cartridge Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Cytosorb Cartridge Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Polymyxin B Column Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Polymyxin B Column Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Polymyxin B Column Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 32. Global Extracorporeal Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Extracorporeal Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Extracorporeal Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Continuous Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Continuous Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Continuous Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Intermittent Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Intermittent Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Intermittent Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Intravascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Intravascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Intravascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Central Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Central Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Central Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Peripheral Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Peripheral Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Peripheral Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2017-2032 (USD Million)
TABLE 51. Global Activated Carbon Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Activated Carbon Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Activated Carbon Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Granular Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Granular Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Granular Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Powdered Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Powdered Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Powdered Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Synthetic Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Synthetic Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Synthetic Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Polymethyl Methacrylate Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Polymethyl Methacrylate Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Polymethyl Methacrylate Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Styrene Divinylbenzene Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Styrene Divinylbenzene Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Styrene Divinylbenzene Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Zeolites Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Zeolites Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Zeolites Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Clinoptilolite Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Clinoptilolite Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Clinoptilolite Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Mordenite Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Mordenite Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Mordenite Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Critical Care Adsorption Solutions Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 79. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Neonatal Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Neonatal Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Neonatal Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Full Term Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Full Term Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Full Term Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Preterm Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Preterm Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Preterm Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Infant Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Infant Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Infant Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Toddler Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Toddler Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Toddler Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Critical Care Adsorption Solutions Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. Global Cytokine Storm Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Cytokine Storm Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Cytokine Storm Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global CAR-T Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global CAR-T Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global CAR-T Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global COVID-19 Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global COVID-19 Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global COVID-19 Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Drug Overdose Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Drug Overdose Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Drug Overdose Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Acetaminophen Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Acetaminophen Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Acetaminophen Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Opioid Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Opioid Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Opioid Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Liver Failure Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Liver Failure Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Liver Failure Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Acute Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Acute Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Acute Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Chronic Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Chronic Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Chronic Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Sepsis Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Sepsis Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Sepsis Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Gram Negative Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Gram Negative Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Gram Negative Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Gram Positive Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Gram Positive Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Gram Positive Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Critical Care Adsorption Solutions Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Non-Teaching Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Non-Teaching Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Non-Teaching Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Teaching Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Teaching Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Teaching Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Critical Care Adsorption Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Hemofiltration Adsorber, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Hemoperfusion Cartridge, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Plasma Adsorption Column, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Extracorporeal, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Intravascular, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Activated Carbon, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Zeolites, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Neonatal, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Cytokine Storm, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Drug Overdose, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Liver Failure, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Sepsis, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Critical Care Adsorption Solutions Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Critical Care Adsorption Solutions Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 176. North America Critical Care Adsorption Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. North America Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. North America Critical Care Adsorption Solutions Market Size, by Hemofiltration Adsorber, 2017-2032 (USD Million)
TABLE 179. North America Critical Care Adsorption Solutions Market Size, by Hemoperfusion Cartridge, 2017-2032 (USD Million)
TABLE 180. North America Critical Care Adsorption Solutions Market Size, by Plasma Adsorption Column, 2017-2032 (USD Million)
TABLE 181. North America Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 182. North America Critical Care Adsorption Solutions Market Size, by Extracorporeal, 2017-2032 (USD Million)
TABLE 183. North America Critical Care Adsorption Solutions Market Size, by Intravascular, 2017-2032 (USD Million)
TABLE 184. North America Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2017-2032 (USD Million)
TABLE 185. North America Critical Care Adsorption Solutions Market Size, by Activated Carbon, 2017-2032 (USD Million)
TABLE 186. North America Critical Care Adsorption Solutions Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 187. North America Critical Care Adsorption Solutions Market Size, by Zeolites, 2017-2032 (USD Million)
TABLE 188. North America Critical Care Adsorption Solutions Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 189. North America Critical Care Adsorption Solutions Market Size, by Neonatal, 2017-2032 (USD Million)
TABLE 190. North America Critical Care Adsorption Solutions Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 191. North America Critical Care Adsorption Solutions Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. North America Critical Care Adsorption Solutions Market Size, by Cytokine Storm, 2017-2032 (USD Million)
TABLE 193. North America Critical Care Adsorption Solutions Market Size, by Drug Overdose, 2017-2032 (USD Million)
TABLE 194. North America Critical Care Adsorption Solutions Market Size, by Liver Failure, 2017-2032 (USD Million)
TABLE 195. North America Critical Care Adsorption Solutions Market Size, by Sepsis, 2017-2032 (USD Million)
TABLE 196. North America Critical Care Adsorption Solutions Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. North America Critical Care Adsorption Solutions Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 198. Latin America Critical Care Adsorption Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 199. Latin America Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Latin America Critical Care Adsorption Solutions Market Size, by Hemofiltration Adsorber, 2017-2032 (USD Million)
TABLE 201. Latin America Critical Care Adsorption Solutions Market Size, by Hemoperfusion Cartridge, 2017-2032 (USD Million)
TABLE 202. Latin America Critical Care Adsorption Solutions Market Size, by Plasma Adsorption Column, 2017-2032 (USD Million)
TABLE 203. Latin America Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 204. Latin America Critical Care Adsorption Solutions Market Size, by Extracorporeal, 2017-2032 (USD Million)
TABLE 205. Latin America Critical Care Adsorption Solutions Market Size, by Intravascular, 2017-2032 (USD Million)
TABLE 206. Latin America Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2017-2032 (USD Million)
TABLE 207. Latin America Critical Care Adsorption Solutions Market Size, by Activated Carbon, 2017-2032 (USD Million)
TABLE 208. Latin America Critical Care Adsorption Solutions Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 209. Latin America Critical Care Adsorption Solutions Market Size, by Zeolites, 2017-2032 (USD Million)
TABLE 210. Latin America Critical Care Adsorption Solutions Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 211. Latin America Critical Care Adsorption Solutions Market Size, by Neonatal, 2017-2032 (USD Million)
TABLE 212. Latin America Critical Care Adsorption Solutions Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 213. Latin America Critical Care Adsorption Solutions Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Latin America Critical Care Adsorption Solutions Market Size, by Cytokine Storm, 2017-2032 (USD Million)
TABLE 215. Latin America Critical Care Adsorption Solutions Market Size, by Drug Overdose, 2017-2032 (USD Million)
TABLE 216. Latin America Critical Care Adsorption Solutions Market Size, by Liver Failure, 2017-2032 (USD Million)
TABLE 217. Latin America Critical Care Adsorption Solutions Market Size, by Sepsis, 2017-2032 (USD Million)
TABLE 218. Latin America Critical Care Adsorption Solutions Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Latin America Critical Care Adsorption Solutions Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 220. Europe Critical Care Adsorption Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 221. Europe Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Europe Critical Care Adsorption Solutions Market Size, by Hemofiltration Adsorber, 2017-2032 (USD Million)
TABLE 223. Europe Critical Care Adsorption Solutions Market Size, by Hemoperfusion Cartridge, 2017-2032 (USD Million)
TABLE 224. Europe Critical Care Adsorption Solutions Market Size, by Plasma Adsorption Column, 2017-2032 (USD Million)
TABLE 225. Europe Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. Europe Critical Care Adsorption Solutions Market Size, by Extracorporeal, 2017-2032 (USD Million)
TABLE 227. Europe Critical Care Adsorption Solutions Market Size, by Intravascular, 2017-2032 (USD Million)
TABLE 228. Europe Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2017-2032 (USD Million)
TABLE 229. Europe Critical Care Adsorption Solutions Market Size, by Activated Carbon, 2017-2032 (USD Million)
TABLE 230. Europe Critical Care Adsorption Solutions Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 231. Europe Critical Care Adsorption Solutions Market Size, by Zeolites, 2017-2032 (USD Million)
TABLE 232. Europe Critical Care Adsorption Solutions Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 233. Europe Critical Care Adsorption Solutions Market Size, by Neonatal, 2017-2032 (USD Million)
TABLE 234. Europe Critical Care Adsorption Solutions Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 235. Europe Critical Care Adsorption Solutions Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Europe Critical Care Adsorption Solutions Market Size, by Cytokine Storm, 2017-2032 (USD Million)
TABLE 237. Europe Critical Care Adsorption Solutions Market Size, by Drug Overdose, 2017-2032 (USD Million)
TABLE 238. Europe Critical Care Adsorption Solutions Market Size, by Liver Failure, 2017-2032 (USD Million)
TABLE 239. Europe Critical Care Adsorption Solutions Market Size, by Sepsis, 2017-2032 (USD Million)
TABLE 240. Europe Critical Care Adsorption Solutions Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Europe Critical Care Adsorption Solutions Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 242. Middle East Critical Care Adsorption Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 243. Middle East Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. Middle East Critical Care Adsorption Solutions Market Size, by Hemofiltration Adsorber, 2017-2032 (USD Million)
TABLE 245. Middle East Critical Care Adsorption Solutions Market Size, by Hemoperfusion Cartridge, 2017-2032 (USD Million)
TABLE 246. Middle East Critical Care Adsorption Solutions Market Size, by Plasma Adsorption Column, 2017-2032 (USD Million)
TABLE 247. Middle East Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. Middle East Critical Care Adsorption Solutions Market Size, by Extracorporeal, 2017-2032 (USD Million)
TABLE 249. Middle East Critical Care Adsorption Solutions Market Size, by Intravascular, 2017-2032 (USD Million)
TABLE 250. Middle East Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2017-2032 (USD Million)
TABLE 251. Middle East Critical Care Adsorption Solutions Market Size, by Activated Carbon, 2017-2032 (USD Million)
TABLE 252. Middle East Critical Care Adsorption Solutions Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 253. Middle East Critical Care Adsorption Solutions Market Size, by Zeolites, 2017-2032 (USD Million)
TABLE 254. Middle East Critical Care Adsorption Solutions Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 255. Middle East Critical Care Adsorption Solutions Market Size, by Neonatal, 2017-2032 (USD Million)
TABLE 256. Middle East Critical Care Adsorption Solutions Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 257. Middle East Critical Care Adsorption Solutions Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Middle East Critical Care Adsorption Solutions Market Size, by Cytokine Storm, 2017-2032 (USD Million)
TABLE 259. Middle East Critical Care Adsorption Solutions Market Size, by Drug Overdose, 2017-2032 (USD Million)
TABLE 260. Middle East Critical Care Adsorption Solutions Market Size, by Liver Failure, 2017-2032 (USD Million)
TABLE 261. Middle East Critical Care Adsorption Solutions Market Size, by Sepsis, 2017-2032 (USD Million)
TABLE 262. Middle East Critical Care Adsorption Solutions Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Middle East Critical Care Adsorption Solutions Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 264. Africa Critical Care Adsorption Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 265. Africa Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. Africa Critical Care Adsorption Solutions Market Size, by Hemofiltration Adsorber, 2017-2032 (USD Million)
TABLE 267. Africa Critical Care Adsorption Solutions Market Size, by Hemoperfusion Cartridge, 2017-2032 (USD Million)
TABLE 268. Africa Critical Care Adsorption Solutions Market Size, by Plasma Adsorption Column, 2017-2032 (USD Million)
TABLE 269. Africa Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 270. Africa Critical Care Adsorption Solutions Market Size, by Extracorporeal, 2017-2032 (USD Million)
TABLE 271. Africa Critical Care Adsorption Solutions Market Size, by Intravascular, 2017-2032 (USD Million)
TABLE 272. Africa Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2017-2032 (USD Million)
TABLE 273. Africa Critical Care Adsorption Solutions Market Size, by Activated Carbon, 2017-2032 (USD Million)
TABLE 274. Africa Critical Care Adsorption Solutions Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 275. Africa Critical Care Adsorption Solutions Market Size, by Zeolites, 2017-2032 (USD Million)
TABLE 276. Africa Critical Care Adsorption Solutions Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 277. Africa Critical Care Adsorption Solutions Market Size, by Neonatal, 2017-2032 (USD Million)
TABLE 278. Africa Critical Care Adsorption Solutions Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 279. Africa Critical Care Adsorption Solutions Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Africa Critical Care Adsorption Solutions Market Size, by Cytokine Storm, 2017-2032 (USD Million)
TABLE 281. Africa Critical Care Adsorption Solutions Market Size, by Drug Overdose, 2017-2032 (USD Million)
TABLE 282. Africa Critical Care Adsorption Solutions Market Size, by Liver Failure, 2017-2032 (USD Million)
TABLE 283. Africa Critical Care Adsorption Solutions Market Size, by Sepsis, 2017-2032 (USD Million)
TABLE 284. Africa Critical Care Adsorption Solutions Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Africa Critical Care Adsorption Solutions Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 286. Global Critical Care Adsorption Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 287. ASEAN Critical Care Adsorption Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 288. ASEAN Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. ASEAN Critical Care Adsorption Solutions Market Size, by Hemofiltration Adsorber, 2017-2032 (USD Million)
TABLE 290. ASEAN Critical Care Adsorption Solutions Market Size, by Hemoperfusion Cartridge, 2017-2032 (USD Million)
TABLE 291. ASEAN Critical Care Adsorption Solutions Market Size, by Plasma Adsorption Column, 2017-2032 (USD Million)
TABLE 292. ASEAN Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 293. ASEAN Critical Care Adsorption Solutions Market Size, by Extracorporeal, 2017-2032 (USD Million)
TABLE 294. ASEAN Critical Care Adsorption Solutions Market Size, by Intravascular, 2017-2032 (USD Million)
TABLE 295. ASEAN Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2017-2032 (USD Million)
TABLE 296. ASEAN Critical Care Adsorption Solutions Market Size, by Activated Carbon, 2017-2032 (USD Million)
TABLE 297. ASEAN Critical Care Adsorption Solutions Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 298. ASEAN Critical Care Adsorption Solutions Market Size, by Zeolites, 2017-2032 (USD Million)
TABLE 299. ASEAN Critical Care Adsorption Solutions Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 300. ASEAN Critical Care Adsorption Solutions Market Size, by Neonatal, 2017-2032 (USD Million)
TABLE 301. ASEAN Critical Care Adsorption Solutions Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 302. ASEAN Critical Care Adsorption Solutions Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. ASEAN Critical Care Adsorption Solutions Market Size, by Cytokine Storm, 2017-2032 (USD Million)
TABLE 304. ASEAN Critical Care Adsorption Solutions Market Size, by Drug Overdose, 2017-2032 (USD Million)
TABLE 305. ASEAN Critical Care Adsorption Solutions Market Size, by Liver Failure, 2017-2032 (USD Million)
TABLE 306. ASEAN Critical Care Adsorption Solutions Market Size, by Sepsis, 2017-2032 (USD Million)
TABLE 307. ASEAN Critical Care Adsorption Solutions Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. ASEAN Critical Care Adsorption Solutions Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 309. GCC Critical Care Adsorption Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 310. GCC Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 311. GCC Critical Care Adsorption Solutions Market Size, by Hemofiltration Adsorber, 2017-2032 (USD Million)
TABLE 312. GCC Critical Care Adsorption Solutions Market Size, by Hemoperfusion Cartridge, 2017-2032 (USD Million)
TABLE 313. GCC Critical Care Adsorption Solutions Market Size, by Plasma Adsorption Column, 2017-2032 (USD Million)
TABLE 314. GCC Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 315. GCC Critical Care Adsorption Solutions Market Size, by Extracorporeal, 2017-2032 (USD Million)
TABLE 316. GCC Critical Care Adsorption Solutions Market Size, by Intravascular, 2017-2032 (USD Million)
TABLE 317. GCC Critical Care Adsorption Solutions Market Size, by Adsorbent Material, 2017-2032 (USD Million)
TABLE 318. GCC Critical Care Adsorption Solutions Market Size, by Activated Carbon, 2017-2032 (USD Million)
TABLE 319. GCC Critical Care Adsorption Solutions Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 320. GCC Critical Care Adsorption Solutions Market Size, by Zeolites, 2017-2032 (USD Million)
TABLE 321. GCC Critical Care Adsorption Solutions Market Size, by Patient Type, 2017-2032 (USD Million)
TABLE 322. GCC Critical Care Adsorption Solutions Market Size, by Neonatal, 2017-2032 (USD Million)
TABLE 323. GCC Critical Care Adsorption Solutions Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 324. GCC Critical Care Adsorption Solutions Market Size, by Application, 2017-2032 (USD Million)
TABLE 325. GCC Critical Care Adsorption Solutions Market Size, by Cytokine Storm, 2017-2032 (USD Million)
TABLE 326. GCC Critical Care Adsorption Solutions Market Size, by Drug Overdose, 2017-2032 (USD Million)
TABLE 327. GCC Critical Care Adsorption Solutions Market Size, by Liver Failure, 2017-2032 (USD Million)
TABLE 328. GCC Critical Care Adsorption Solutions Market Size, by Sepsis, 2017-2032 (USD Million)
TABLE 329. GCC Critical Care Adsorption Solutions Market Size, by End User, 2017-2032 (USD Million)
TABLE 330. GCC Critical Care Adsorption Solutions Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 331. European Union Critical Care Adsorption Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 332. European Union Critical Care Adsorption Solutions Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 333. European Union Critical Care Adsorption Solutions Market Size, by Hemofiltration Adsorber, 2017-2032 (USD Million)
TABLE 334. European Union Critical Care Adsorption Solutions Market Size, by Hemoperfusion Cartridge, 2017-2032 (USD Million)
TABLE 335. European Union Critical Care Adsorption Solutions Market Size, by Plasma Adsorption Column, 2017-2032 (USD Million)
TABLE 336. European Union Critical Care Adsorption Solutions Market Size, by Technology, 2017-2032 (USD Million)
TABLE 337. European Union Critical Care Adsorption Solutions Market Size, by Extracorporeal, 2017-2032 (USD Million)
TABLE 338. European Union Critical Care Adsorption Solutions Market Size, by Intravascular, 2017-2032 (USD Million)
TAB

Companies Mentioned

  • Adsorba Medical AB
  • Aferetica S.r.l.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • BioLogic-DT, LLC
  • Bionic Medizintechnik GmbH
  • CytoSorbents Corporation
  • CytoSorbents Europe GmbH
  • ExThera Medical Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Gambro AB
  • Hemoclean Co., Ltd.
  • Jafron Biomedical Co., Ltd.
  • Jiangsu Jafron Biomedical Co., Ltd.
  • Kaneka Corporation
  • Kawasumi Laboratories, Inc.
  • Medica S.p.A.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Polymed Medical Devices
  • SeaStar Medical Holding Corporation
  • Shandong Qidong Medical Devices Co., Ltd.
  • Spectral Medical Inc.
  • Suzhou Tiancheng Medical Devices Co., Ltd.
  • Terumo Corporation
  • Toray Industries, Inc.
  • Toray Medical Co., Ltd.
  • Zhejiang Tianjin Medical Devices Co., Ltd.

Related Topics

Related Reports

Critical Care Diagnostics Market - Global Forecast 2026-2032 - Product Image

Critical Care Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Critical Care Equipment Market - Global Forecast 2026-2032 - Product Image

Critical Care Equipment Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Critical Care Diagnostics - Global Strategic Business Report - Product Image

Critical Care Diagnostics - Global Strategic Business Report

  • Report
  • 352 Pages
  • Global
From
Critical Care Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Critical Care Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 114 Pages
  • Global
From
Critical Care Antiarrhythmic Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class, Disease Type, Route Of Administration, Distribution Channel - Product Image

Critical Care Antiarrhythmic Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class, Disease Type, Route Of Administration, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.